Co-Authors
This is a "connection" page, showing publications co-authored by Katie Doores and Paul Fields.
Connection Strength
0.117
-
Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study. Lancet Oncol. 2021 06; 22(6):765-778.
Score: 0.059
-
Acute Immune Signatures and Their Legacies in Severe Acute Respiratory Syndrome Coronavirus-2 Infected Cancer Patients. Cancer Cell. 2021 02 08; 39(2):257-275.e6.
Score: 0.058